Prostaglandin E2 promotes intestinal tumor growth via DNA methylation

Dianren Xia1, Dingzhi Wang, Sun-Hee Kim

  • 1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Nature Medicine
|January 25, 2012
PubMed

Insights

Prostaglandin E2 (PGE2) silences tumor-suppressor and DNA-repair genes via DNA methylation, promoting cancer growth. This research reveals a new role for PGE2 in advancing tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Aberrant DNA methylation is a key mechanism for silencing tumor-suppressor and DNA-repair genes in cancer.
  • The precise mechanisms driving DNA methylation alterations in cancer remain largely unknown.

Purpose of the Study:

  • To investigate the role of prostaglandin E2 (PGE2) in regulating DNA methylation of critical genes during cancer development.
  • To elucidate the functional impact of PGE2-mediated DNA methylation on tumor progression.

Main Methods:

  • Analysis of DNA methylation patterns in cancer cells.
  • Assessment of gene expression changes in response to PGE2.
  • Correlation of PGE2 levels with gene silencing and tumor growth.

Main Results:

  • Prostaglandin E2 (PGE2) was found to induce DNA methylation.
  • PGE2-mediated DNA methylation leads to the silencing of specific tumor-suppressor and DNA-repair genes.
  • This silencing effect was linked to the promotion of tumor growth.

Conclusions:

  • Prostaglandin E2 (PGE2) plays a significant role in cancer progression by silencing crucial genes through DNA methylation.
  • These findings identify a novel pathway involving PGE2 in epigenetic regulation during tumorigenesis.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K